Galatea Bio Inc.
PrivateLast Round
Series A
Mar 27, 2025
Total Funding Raised
$25M
Momentum Score
25 /100
Company Overview
Galatea Bio Inc. is a biotechnology company that aims to advance precision medicine by using AI-driven data analytics and genomic research. The company focuses on large-scale, diverse patient populations, particularly those of non-European ancestry, to address the lack of diversity in genomic data. It operates the Galatea Global Biobank, with a goal of sequencing 10 million participants to accelerate biomarker and drug target discovery, enhance clinical diagnostics, and support biopharma partnerships. Galatea Bio operates a CAP-accredited, high-complexity clinical laboratory in Miami, providing sequencing, molecular diagnostics, and AI-enhanced genomic analysis.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Drug Discovery, Medical AI, Clinical Trials
Business Model
B2B
Customer Profile
Data as a Service, Services & Consulting, Subscription SaaS, Government Contracts
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Galatea Bio Inc. Comps
Public and private peers based on sector, stage, and business model.
Galatea Bio Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Mar 27, 2025 |
Key People
Founding team and executive leadership
Galatea Bio Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Founder Collective | Series A |
| Digitalis Ventures | Series A |
| F-Prime Capital | Series A |
| F-Prime Capital | Series A |
| CEI Ventures | Series A |
| AME Cloud Ventures | Series A |
| Alexandria Venture Investments | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 23, 2025
Developing genetic disease risk assays with Fabric Genomics.
- Jun 23, 2025
Partnered with Fabric Genomics to co-develop genetic disease risk assays.
Galatea Bio Inc. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Galatea Bio Inc.'s valuation, stock price, and market status.
